Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Glanville

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nature Communications|November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoireYik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
The Journal of Clinical Investigation|November 20, 2012
B cell exchange across the blood-brain barrier in multiple sclerosisH-Christian von Büdingen, Tracy C Kuo, Marina Sirota, et al.
Nature|June 22, 2017
Identifying specificity groups in the T cell receptor repertoireJacob Glanville, Huang Huang, Allison Nau, et al.
Cell|May 3, 2025
Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodiesJacob Glanville, Mark Bellin, Sergei Pletnev, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Nature Communications|June 17, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersEdurne Rujas, Iga Kucharska, Yong Zi Tan, et al.
Mabs|February 28, 2018
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regionsAndrew R M Bradbury, Nathan D Trinklein, Holger Thie, et al.
Cell Host & Microbe|July 2, 2014
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangementsKatherine J L Jackson, Yi Liu, Krishna M Roskin, et al.
Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature Communications|November 19, 2016
Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoireYik Andy Yeung, Davide Foletti, Xiaodi Deng, et al.
The Journal of Clinical Investigation|November 20, 2012
B cell exchange across the blood-brain barrier in multiple sclerosisH-Christian von Büdingen, Tracy C Kuo, Marina Sirota, et al.
Nature|June 22, 2017
Identifying specificity groups in the T cell receptor repertoireJacob Glanville, Huang Huang, Allison Nau, et al.
Cell|May 3, 2025
Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodiesJacob Glanville, Mark Bellin, Sergei Pletnev, et al.
Journal of Molecular Biology|February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potentialCiara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Nature Communications|June 17, 2021
Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersEdurne Rujas, Iga Kucharska, Yong Zi Tan, et al.
Mabs|February 28, 2018
When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regionsAndrew R M Bradbury, Nathan D Trinklein, Holger Thie, et al.
Cell Host & Microbe|July 2, 2014
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangementsKatherine J L Jackson, Yi Liu, Krishna M Roskin, et al.
Nature Medicine|January 3, 2024
A candidate antibody drug for prevention of malariaKatherine L Williams, Steve Guerrero, Yevel Flores-Garcia, et al.
Clinical Immunology (Orlando, Fla.)|October 17, 2017
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigensJeff DeFalco, Michael Harbell, Amy Manning-Bog, et al.
Pageof 5